Dr. Lal Path Labs Ltd. (LALPATHLAB) — Board Meeting | 6 August 2026
The Board approved the allotment of 211,050 equity shares under the ESOP Plan 2022, increasing paid-up capital to INR 1,67.84 crores across 16,78,48,820 shares of INR 10 each, effective August 6, 2026.
About Dr. Lal Path Labs Ltd. (LALPATHLAB)
Healthcare · Healthcare · Listed on NSE
📡 Get AI alerts when LALPATHLAB files next
Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions
Track LALPATHLAB — Free💡 Ask AI about this filing
📊 More LALPATHLAB filings
- 🔴 Corporate Action — 1 October 2026Dr Lal Pathlabs announced completion of its acquisition of SN Genelab Private Limited on October 1, ...
- 🔴 Corporate Action — 26 September 2026Dr Lal PathLabs announced completion of its Dubai subsidiary's acquisition of an 80% stake in Sunshi...
- 🟡 Board Meeting — 25 September 2026The board announced a meeting on November 4, 2026 to approve unaudited standalone and consolidated f...
- Announcement — 25 September 2026Dr Lal Pathlabs announced a board meeting on November 4, 2026, to approve Q3 and H1 FY27 financial r...
- 🟡 Board Meeting — 24 September 2026Dr Lal Pathlabs announced on September 24, 2026, that its board approved acquiring a 70% stake in SN...
🔥 Also filed on 6 August 2026
Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.
Editorial & Data Transparency Notice
This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.
📡 Get AI alerts when LALPATHLAB files new disclosures
Track LALPATHLAB filings, board meetings, and corporate actions. Free email alerts at 5 PM.
Track LALPATHLAB — FreeFree account · 2 AI queries/day